| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 24 | +58.33% | -1.09% | +0.97% | -2.06% | -2.84% | — |
| 14d | 24 | +41.67% | -0.85% | +1.62% | -2.47% | -0.61% | — |
| 30d | 24 | +37.50% | -3.02% | +4.19% | -7.21% | -3.84% | — |
| 60d | 24 | +70.83% | -13.26% | +4.58% | -17.83% | -22.37% | — |
| 90d | 24 | +70.83% | -16.71% | +5.19% | -21.90% | -19.13% | — |
| 180d | 24(1 pending) | +91.30% | -32.64% | +10.42% | -43.06% | -40.40% | — |
| 1y | 24(1 pending) | +73.91% | -32.81% | +13.70% | -46.51% | -43.19% | — |
| 2y | 24(3 pending) | +95.24% | -59.49% | +29.02% | -88.50% | -94.53% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 1,776 | $2.71 | $4.8K | 390,247 | Jun 18, 2026 | Jun 22, 2026 ↗ | View → |
| ENGN ENGENE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 31,000 | — | — | 31,000 | Jun 16, 2026 | Jun 17, 2026 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 26,046 | $2.07 | $53.9K | 390,023 | Jan 15, 2026 | Jan 20, 2026 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 562,000 | — | — | 562,000 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 94,000 | — | — | 416,069 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 1,790 | $1.79 | $3.2K | 320,069 | Jun 18, 2025 | Jun 20, 2025 ↗ | View → |
| ENGN ENGENE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 22,500 | — | — | 22,500 | Jun 16, 2025 | Jun 16, 2025 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 377,000 | — | — | 377,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 17,378 | $2.20 | $38.2K | 319,859 | Jan 15, 2025 | Jan 17, 2025 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 565,500 | — | — | 565,500 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 94,500 | — | — | 337,237 | Jan 3, 2025 | Jan 7, 2025 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 1,770 | $5.60 | $9.9K | 240,737 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| ENGN ENGENE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 15, 2024 | Jun 18, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 880 | $28.38 | $25.0K | 12,724 | Jun 13, 2024 | Jun 13, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 5,230 | — | — | 13,604 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 12,179 | — | — | 12,179 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 137,642 | $13.33 | $1.83M | 240,507 | Mar 4, 2024 | Mar 5, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 12,358 | $13.00 | $160.7K | 378,149 | Mar 1, 2024 | Mar 5, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 9,697 | $8.74 | $84.8K | 390,507 | Jan 16, 2024 | Jan 18, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 85,000 | — | — | 400,204 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 509,500 | — | — | 509,500 | Jan 4, 2024 | Jan 8, 2024 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 1,704 | $4.85 | $8.3K | 313,402 | Jun 20, 2023 | Jun 22, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 1,775 | — | — | 8,374 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 12,925 | — | — | 12,925 | Jun 14, 2023 | Jun 16, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 580 | $38.34 | $22.2K | 6,599 | Jun 5, 2023 | Jun 7, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE | 7,000 | $29.90 | $209.3K | 14,179 | May 15, 2023 | May 17, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE10b5-1 10b5-1 plan | 7,000 | $41.85 | $292.9K | 7,179 | May 15, 2023 | May 17, 2023 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 7,000 | — | — | 0 | May 15, 2023 | May 17, 2023 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 3,691 | $5.49 | $20.3K | 313,106 | Jan 17, 2023 | Jan 18, 2023 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 386,500 | — | — | 386,500 | Jan 13, 2023 | Jan 18, 2023 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 64,500 | — | — | 316,797 | Jan 13, 2023 | Jan 18, 2023 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 498 | $13.00 | $6.5K | 250,461 | Sep 29, 2022 | Sep 30, 2022 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 23,376 | $13.03 | $304.6K | 250,959 | Sep 28, 2022 | Sep 30, 2022 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 6,126 | $13.01 | $79.7K | 274,335 | Sep 21, 2022 | Sep 22, 2022 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 533 | $56.95 | $30.4K | 7,179 | Jul 11, 2022 | Jul 13, 2022 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 19,500 | — | — | 280,461 | Jun 17, 2022 | Jun 21, 2022 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Jun 17, 2022 | Jun 21, 2022 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 1,160 | — | — | 7,712 | Jun 8, 2022 | Jun 8, 2022 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 8,225 | — | — | 8,225 | Jun 8, 2022 | Jun 8, 2022 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 251,100 | — | — | 251,100 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 41,900 | — | — | 260,961 | Jan 14, 2022 | Jan 19, 2022 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 223 | $26.53 | $5.9K | 219,061 | Sep 29, 2021 | Oct 1, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 8,277 | $27.20 | $225.1K | 219,284 | Sep 29, 2021 | Oct 1, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 3,807 | $26.89 | $102.4K | 227,561 | Jun 21, 2021 | Jun 23, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 4,693 | $26.39 | $123.8K | 231,368 | Jun 21, 2021 | Jun 23, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 7,626 | — | — | 7,626 | Jun 9, 2021 | Jun 11, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 1,066 | — | — | 6,552 | Jun 9, 2021 | Jun 11, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 630 | $62.19 | $39.2K | 5,486 | Jun 4, 2021 | Jun 8, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 3,130 | $32.21 | $100.8K | 236,061 | Mar 30, 2021 | Mar 31, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 11,461 | $30.23 | $346.5K | 241,600 | Mar 30, 2021 | Mar 31, 2021 ↗ | View → |
| NKTX NKARTA, INC. | SALE Chief Executive Officer | 2,409 | $31.24 | $75.3K | 239,191 | Mar 30, 2021 | Mar 31, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASE | 3,000 | $13.98 | $41.9K | 9,116 | Mar 5, 2021 | Mar 9, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 3,000 | — | — | 0 | Mar 5, 2021 | Mar 9, 2021 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 3,000 | $65.88 | $197.6K | 6,116 | Mar 5, 2021 | Mar 9, 2021 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 157,500 | — | — | 157,500 | Jan 8, 2021 | Jan 12, 2021 ↗ | View → |
| NKTX NKARTA, INC. | PURCHASEGRANT Stock grant | 202,400 | — | — | 202,400 | Jul 9, 2020 | Jul 10, 2020 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 8,027 | — | — | 8,027 | Jun 9, 2020 | Jun 11, 2020 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 1,260 | — | — | 6,116 | Jun 9, 2020 | Jun 11, 2020 ↗ | View → |
| PCRX PACIRA BIOSCIENCES, INC. | SALE | 2,025 | $47.46 | $96.1K | 4,856 | Jun 4, 2020 | Jun 8, 2020 ↗ | View → |